Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

HISTORICAL FACTS: 2 | History Defined

GoodRx Stock Could Get a Major Trump Boost. Should You Buy It Here?

With a potential TrumpRx partnership, should investors buy GDRX stock now?

Barchart

Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Trying'

Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to lower prescription drug costs, calling its TrumpRx initiative “a good start,” while still acknowledging its limitations.

Benzinga

TrumpRx.Gov vs. Mark Cuban’s Cost Plus Drugs: Which Saves Retirees More?

Billionaire celebrity Mark Cuban disrupted the prescription drug industry when he launched the digital pharmaceutical marketplace CostPlus Drugs in 2022. President Donald Trump recently announced a...

GOBankingRates

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Things Retirees Need To Know About the New Trump Drug Program

Will TrumpRx help cut prescription costs for uninsured retirees? Learn how this new drug program could impact retirees' prescription budgets come 2026.

GOBankingRates

Trump announces AstraZeneca will offer discount drugs on ‘TrumpRx’ website

TrumpRx.gov, a website where Americans can buy pharmaceutical drugs under President Donald Trump’s new drug pricing plan, is set to begin operation in 2026

The Independent UK

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch

Prescription savings platform GoodRx Holdings Inc. (NASDAQ:GDRX) is reportedly joining the so-called TrumpRx website, signaling an initiative expansion beyond pharmaceutical manufacturers' direct discount programs.

Benzinga

Why AbbVie and Johnson & Johnson Could Outperform Pfizer

Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

TrumpRx Brings Pfizer Into the Green—Is It a Buy?

Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy.

MarketBeat

TrumpRx Is Obamacare in Trump's Handwriting

Pfizer wins big in Trump’s new drug discount gimmick.

Reason

Inside the TrumpRx website and its unusual launch

Trump has been urging prescription drug manufacturers to lower U.S. prices.

Axios

How TrumpRx will work — and why insured Americans may not save any money

Pfizer will now sell drugs to Medicaid at ‘most-favored-nation’ prices, the White House announced

The Independent UK

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

Benzinga

'TrumpRx': President Unveils New Drug Price-Cutting Website As Pfizer Agrees To Slash Costs By 50%

Trump announced a website for consumers to buy medicines at heavily discounted prices. He also forged a deal with Pfizer, where the drugmaker will slash prices for several of its products.

International Business Times UK

TrumpRx: Trump and Pfizer Announce Landmark Deal to Slash US Drug Prices by Up to 85%

TrumpRx will slash US drug prices by up to 85% under a new deal with Pfizer, bringing costs in line with other nations and boosting US investment.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Trump Seals Explosive Pfizer Deal To Cut Drug Prices With New TrumpRx Platform

Donald Trump has struck a headline-grabbing deal with Pfizer to slash US drug prices, launching a TrumpRx platform that bypasses intermediaries and raises major questions over enforcement and patient impact.

The Independent UK

White House weighs creating ‘TrumpRx’ website where citizens can buy meds directly from pharma companies: report

The plan is reportedly part of President Donald Trump’s campaign to force top drugmakers to slash their U.S. prices in line with what they charge in other developed nations

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.